Central Asian Research Index

Tibbiyot, ta’lim va innovatsion tadqiqotlar, 2026, т. 2, № 11, с. 70-78

SARATON BILAN OG‘RIGAN BEMORLARGA TIBBIY YORDAM KO‘RSATISHGA YONDASHUVNING UMUMIY TAMOYILLARI

Sanjar Nurmatovich Atabekov

Аннотация · Abstract

Cancer patients are at an increased risk of severe COVID-19 due to immunosuppression associated with anticancer treatment, regardless of the timing of its administration [1]. An analysis of data conducted in China demonstrated that patients with cancer were five times more likely to contract COVID-19 than individuals without cancer and had a higher likelihood of developing severe infection requiring intensive care [2]. Under these circumstances, the treatment and monitoring of cancer patients become particularly challenging due to their compromised immune status and the aggressive nature of the underlying disease. Quarantine measures implemented in healthcare facilities reflect the increased risk of mortality among cancer patients infected with COVID-19. Therefore, during a pandemic, specific approaches to the management of patients with cancer are required, taking into account the prediction of COVID-19 infection risk and the likelihood of severe disease progression.

Сведения · Details